share_log

Brookfield Infr Partners Analyst Ratings

Benzinga ·  Aug 4, 2023 09:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/04/2023 35.01% RBC Capital $47 → $45 Maintains Outperform
07/11/2023 8.01% Citigroup → $36 Reiterates Neutral → Neutral
05/30/2023 32.01% Credit Suisse → $44 Reiterates Outperform → Outperform
05/04/2023 41.01% RBC Capital → $47 Reiterates → Outperform
04/13/2023 23.01% Wells Fargo $40 → $41 Maintains Overweight
04/13/2023 41.01% RBC Capital → $47 Reiterates → Outperform
11/03/2022 23.01% BMO Capital $46 → $41 Maintains Outperform
08/04/2022 41.01% Wells Fargo $46 → $47 Maintains Overweight
06/30/2022 48.51% Credit Suisse → $49.5 Upgrades Neutral → Outperform
05/05/2022 110.02% RBC Capital $65 → $70 Maintains Outperform
03/31/2022 113.02% BMO Capital $66 → $71 Maintains Outperform
11/04/2021 95.02% RBC Capital $61 → $65 Maintains Outperform
10/13/2021 89.02% Wells Fargo $62 → $63 Maintains Overweight
11/23/2020 Credit Suisse Upgrades Underperform → Neutral
09/25/2020 53.02% B of A Securities $48 → $51 Maintains Buy
09/25/2020 50.02% TD Securities $47 → $50 Maintains Buy
08/19/2020 35.01% Citigroup $41 → $45 Maintains Neutral
08/06/2020 44.01% BMO Capital $47 → $48 Maintains Outperform
07/29/2020 20.01% Credit Suisse → $40 Downgrades Neutral → Underperform
06/18/2020 23.01% Citigroup $36.57 → $41 Maintains Neutral
05/11/2020 38.01% BMO Capital $45 → $46 Maintains Outperform
05/11/2020 50.02% Scotiabank $51 → $50 Maintains Sector Outperform
04/08/2020 35.01% BMO Capital $54 → $45 Maintains Outperform
03/18/2020 59.02% TD Securities $57 → $53 Upgrades Hold → Buy
02/11/2020 71.02% TD Securities $58 → $57 Downgrades Buy → Hold
12/18/2019 74.02% B of A Securities → $58 Reinstates → Buy
09/30/2019 53.02% Barclays $46 → $51 Maintains Equal-Weight
09/27/2019 59.02% RBC Capital $50 → $53 Reiterates → Outperform
09/23/2019 53.02% B of A Securities $47 → $51 Maintains Buy
07/30/2019 41.01% B of A Securities $43 → $47 Maintains Buy
07/18/2019 42.51% Credit Suisse → $47.5 Reinstates → Neutral
07/11/2019 38.01% Barclays → $46 Initiates Coverage On → Equal-Weight
04/25/2019 Credit Suisse Downgrades Outperform → Neutral
11/29/2018 23.01% Citigroup $43 → $41 Maintains Neutral
11/05/2018 41.01% RBC Capital $49 → $47 Maintains Outperform
11/05/2018 32.01% Wells Fargo $46 → $44 Maintains Outperform
08/27/2018 29.01% Citigroup $44 → $43 Maintains Neutral
08/27/2018 29.01% Citigroup → $43 Reinstates → Neutral

What is the target price for Brookfield Infr Partners (BIP)?

The latest price target for Brookfield Infr Partners (NYSE: BIP) was reported by RBC Capital on August 4, 2023. The analyst firm set a price target for $45.00 expecting BIP to rise to within 12 months (a possible 35.01% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Brookfield Infr Partners (BIP)?

The latest analyst rating for Brookfield Infr Partners (NYSE: BIP) was provided by RBC Capital, and Brookfield Infr Partners maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Brookfield Infr Partners (BIP)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Brookfield Infr Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Brookfield Infr Partners was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.

Is the Analyst Rating Brookfield Infr Partners (BIP) correct?

While ratings are subjective and will change, the latest Brookfield Infr Partners (BIP) rating was a maintained with a price target of $47.00 to $45.00. The current price Brookfield Infr Partners (BIP) is trading at is $33.33, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment